Treatments that activate the AMPK/SIRT1 axis, such as myo-inositol and semaglutide, have been shown to reduce inflammatory cytokines and fibrosis in PCOS models and aged ovaries45,67. The gene discussed is SIRT1; the disease is polycystic ovary syndrome.